Hôpital Lariboisière, UFR de Médecine Paris Diderot, Département de Médecine Interne, 2 rue Ambroise Paré, 75010 Paris
- Key words: parenterally-transmitted non-A, non-B Hepatitis, genotype, antiviral agent, clinical pathway
- DOI : 10.1684/med.2018.344
- Page(s) : 332-5
- Published in: 2018
The hepatitis C appears on epidemic mode less than forty years ago. After virus identification, several treatments more and more effective were approved with a possibility, for the next ten years, to observe a total eradication of the disease. Treatments are less and less expansive, have a better safety and tolerability, with an efficacy close to 100 %. Nevertheless, we still need to treat only patients who need to be treated in a global approach of the hepatic disease.